Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose: Extended sleeve lobectomy is a challenging surgery. While induction chemoradiotherapy (ChRT) followed by surgery is one of the therapeutic strategies used for locally advanced non-small cell lung cancer (NSCLC), ChRT can impair the anastomotic healing potential. We herein present our experience with cases who underwent an extended sleeve lobectomy after induction ChRT. Methods: The medical records of patients who underwent a surgery for NSCLC after ChRT were reviewed. Results: Between December 2007 and January 2013, nine patients underwent an extended sleeve lobectomy; the left lingular division and lower lobe in four patients, the right upper lobe and trachea in one patient, the carina and trachea in one patient, the right middle and lower lobes in one patient, the right upper and middle lobes and carina in one patient and the right upper lobe and superior segment of the lower lobe in one patient. While no postoperative 90-day deaths occurred, one case developed a bronchopleural fistula on postoperative day (POD) 25 and one case developed a bronchovascular fistula on POD 163. No cases of local recurrence developed. Conclusions: Our experience suggests that an extended sleeve lobectomy after induction ChRT is feasible, but careful patient selection and perioperative management are mandatory.

Original languageEnglish
Pages (from-to)1121-1126
Number of pages6
JournalSurgery Today
Volume45
Issue number9
DOIs
Publication statusPublished - Sep 17 2015

Fingerprint

Chemoradiotherapy
Non-Small Cell Lung Carcinoma
Patient Rights
Trachea
Fistula
Patient Selection
Medical Records
Recurrence

Keywords

  • Chemoradiotherapy
  • Induction therapy
  • Lung cancer
  • Sleeve lobectomy

ASJC Scopus subject areas

  • Surgery

Cite this

Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer. / Toyooka, Shinichi; Sou, Junichi; Yamamoto, Hiromasa; Yamane, Masaomi; Hattori, Shigeru; Shien, Kazuhiko; Miyoshi, Kentaroh; Sugimoto, Seiichiro; Oto, Takahiro; Miyoshi, Shinichiro.

In: Surgery Today, Vol. 45, No. 9, 17.09.2015, p. 1121-1126.

Research output: Contribution to journalArticle

@article{7d96684cf61241a0a38f0ab532313ee6,
title = "Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer",
abstract = "Purpose: Extended sleeve lobectomy is a challenging surgery. While induction chemoradiotherapy (ChRT) followed by surgery is one of the therapeutic strategies used for locally advanced non-small cell lung cancer (NSCLC), ChRT can impair the anastomotic healing potential. We herein present our experience with cases who underwent an extended sleeve lobectomy after induction ChRT. Methods: The medical records of patients who underwent a surgery for NSCLC after ChRT were reviewed. Results: Between December 2007 and January 2013, nine patients underwent an extended sleeve lobectomy; the left lingular division and lower lobe in four patients, the right upper lobe and trachea in one patient, the carina and trachea in one patient, the right middle and lower lobes in one patient, the right upper and middle lobes and carina in one patient and the right upper lobe and superior segment of the lower lobe in one patient. While no postoperative 90-day deaths occurred, one case developed a bronchopleural fistula on postoperative day (POD) 25 and one case developed a bronchovascular fistula on POD 163. No cases of local recurrence developed. Conclusions: Our experience suggests that an extended sleeve lobectomy after induction ChRT is feasible, but careful patient selection and perioperative management are mandatory.",
keywords = "Chemoradiotherapy, Induction therapy, Lung cancer, Sleeve lobectomy",
author = "Shinichi Toyooka and Junichi Sou and Hiromasa Yamamoto and Masaomi Yamane and Shigeru Hattori and Kazuhiko Shien and Kentaroh Miyoshi and Seiichiro Sugimoto and Takahiro Oto and Shinichiro Miyoshi",
year = "2015",
month = "9",
day = "17",
doi = "10.1007/s00595-014-1025-y",
language = "English",
volume = "45",
pages = "1121--1126",
journal = "Japanese Journal of Surgery",
issn = "0941-1291",
publisher = "Springer Japan",
number = "9",

}

TY - JOUR

T1 - Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer

AU - Toyooka, Shinichi

AU - Sou, Junichi

AU - Yamamoto, Hiromasa

AU - Yamane, Masaomi

AU - Hattori, Shigeru

AU - Shien, Kazuhiko

AU - Miyoshi, Kentaroh

AU - Sugimoto, Seiichiro

AU - Oto, Takahiro

AU - Miyoshi, Shinichiro

PY - 2015/9/17

Y1 - 2015/9/17

N2 - Purpose: Extended sleeve lobectomy is a challenging surgery. While induction chemoradiotherapy (ChRT) followed by surgery is one of the therapeutic strategies used for locally advanced non-small cell lung cancer (NSCLC), ChRT can impair the anastomotic healing potential. We herein present our experience with cases who underwent an extended sleeve lobectomy after induction ChRT. Methods: The medical records of patients who underwent a surgery for NSCLC after ChRT were reviewed. Results: Between December 2007 and January 2013, nine patients underwent an extended sleeve lobectomy; the left lingular division and lower lobe in four patients, the right upper lobe and trachea in one patient, the carina and trachea in one patient, the right middle and lower lobes in one patient, the right upper and middle lobes and carina in one patient and the right upper lobe and superior segment of the lower lobe in one patient. While no postoperative 90-day deaths occurred, one case developed a bronchopleural fistula on postoperative day (POD) 25 and one case developed a bronchovascular fistula on POD 163. No cases of local recurrence developed. Conclusions: Our experience suggests that an extended sleeve lobectomy after induction ChRT is feasible, but careful patient selection and perioperative management are mandatory.

AB - Purpose: Extended sleeve lobectomy is a challenging surgery. While induction chemoradiotherapy (ChRT) followed by surgery is one of the therapeutic strategies used for locally advanced non-small cell lung cancer (NSCLC), ChRT can impair the anastomotic healing potential. We herein present our experience with cases who underwent an extended sleeve lobectomy after induction ChRT. Methods: The medical records of patients who underwent a surgery for NSCLC after ChRT were reviewed. Results: Between December 2007 and January 2013, nine patients underwent an extended sleeve lobectomy; the left lingular division and lower lobe in four patients, the right upper lobe and trachea in one patient, the carina and trachea in one patient, the right middle and lower lobes in one patient, the right upper and middle lobes and carina in one patient and the right upper lobe and superior segment of the lower lobe in one patient. While no postoperative 90-day deaths occurred, one case developed a bronchopleural fistula on postoperative day (POD) 25 and one case developed a bronchovascular fistula on POD 163. No cases of local recurrence developed. Conclusions: Our experience suggests that an extended sleeve lobectomy after induction ChRT is feasible, but careful patient selection and perioperative management are mandatory.

KW - Chemoradiotherapy

KW - Induction therapy

KW - Lung cancer

KW - Sleeve lobectomy

UR - http://www.scopus.com/inward/record.url?scp=84939203848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939203848&partnerID=8YFLogxK

U2 - 10.1007/s00595-014-1025-y

DO - 10.1007/s00595-014-1025-y

M3 - Article

VL - 45

SP - 1121

EP - 1126

JO - Japanese Journal of Surgery

JF - Japanese Journal of Surgery

SN - 0941-1291

IS - 9

ER -